Literature DB >> 16961788

The prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patients.

G G Schoonman1, D J Evers, G M Terwindt, J G van Dijk, M D Ferrari.   

Abstract

Migraine attacks are often preceded by premonitory symptoms. Prevalence rates of migraine patients reporting one or more premonitory symptoms show considerable variability and rates range between 12% and 79%. Sources of variability might be differences in study population or research design. Using a questionnaire, we retrospectively studied the prevalence of 12 predefined premonitory symptoms in a clinic-based population. Of 461 migraine patients, 374 (81%) responded. At least one premonitory symptom was reported by 86.9% and 71.1% reported two or more. The most frequently reported premonitory symptoms were fatigue (46.5%), phonophobia (36.4%) and yawning (35.8%). The mean number of premonitory symptoms per person was 3.2 (+/- 2.5). Women reported 3.3 premonitory symptoms compared with 2.5 symptoms in men (P = 0.01). Age, education, migraine subtype (with or without aura) and mean attack frequency had no effect on the mean number of symptoms per individual. In conclusion, premonitory symptoms are frequently reported by migraine patients. Sensitivity and specificity of premonitory symptoms for migraine need to be assessed using prospective methods.

Entities:  

Mesh:

Year:  2006        PMID: 16961788     DOI: 10.1111/j.1468-2982.2006.01195.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  32 in total

1.  Hypothalamic regulation of headache and migraine.

Authors:  Arne May; Rami Burstein
Journal:  Cephalalgia       Date:  2019-08-29       Impact factor: 6.292

Review 2.  Migraine: multiple processes, complex pathophysiology.

Authors:  Rami Burstein; Rodrigo Noseda; David Borsook
Journal:  J Neurosci       Date:  2015-04-29       Impact factor: 6.167

Review 3.  ASICs as therapeutic targets for migraine.

Authors:  Greg Dussor
Journal:  Neuropharmacology       Date:  2015-01-09       Impact factor: 5.250

4.  Relief Following Chronic Stress Augments Spreading Depolarization Susceptibility in Familial Hemiplegic Migraine Mice.

Authors:  Mustafa Balkaya; Jessica L Seidel; Homa Sadeghian; Tao Qin; David Y Chung; Katharina Eikermann-Haerter; Arn M J M van den Maagdenberg; Michel D Ferrari; Cenk Ayata
Journal:  Neuroscience       Date:  2019-07-09       Impact factor: 3.590

Review 5.  Understanding migraine as a cycling brain syndrome: reviewing the evidence from functional imaging.

Authors:  Arne May
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

6.  Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets.

Authors:  Kristian Agmund Haanes; Lars Edvinsson
Journal:  CNS Drugs       Date:  2019-06       Impact factor: 5.749

7.  Relief of menstrual symptoms and migraine with a single-tablet formulation of sumatriptan and naproxen sodium.

Authors:  Vincent T Martin; Jeanne Ballard; Michael P Diamond; Lisa K Mannix; Frederick J Derosier; Shelly E Lener; Alok Krishen; Susan A McDonald
Journal:  J Womens Health (Larchmt)       Date:  2014-02-28       Impact factor: 2.681

Review 8.  Cerebral hemodynamics in the different phases of migraine and cluster headache.

Authors:  Jakob M Hansen; Christoph J Schankin
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-31       Impact factor: 6.200

9.  High prevalence of Dopaminergic Premonitory Symptoms in migraine patients with Restless Legs Syndrome: a pathogenetic link?

Authors:  Daniela Cologno; Giulio Cicarelli; Vittorio Petretta; Florindo d'Onofrio; Gennaro Bussone
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

Review 10.  Triggers, Protectors, and Predictors in Episodic Migraine.

Authors:  Michael J Marmura
Journal:  Curr Pain Headache Rep       Date:  2018-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.